These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 7827030)

  • 1. Engineering of fibroblast growth factor: alteration of receptor binding specificity.
    Seddon AP; Aviezer D; Li LY; Böhlen P; Yayon A
    Biochemistry; 1995 Jan; 34(3):731-6. PubMed ID: 7827030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of residues important both for primary receptor binding and specificity in fibroblast growth factor-7.
    Sher I; Lang T; Lubinsky-Mink S; Kuhn J; Adir N; Chatterjee S; Schomburg D; Ron D
    J Biol Chem; 2000 Nov; 275(45):34881-6. PubMed ID: 10950949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cleavage of K-FGF produces a truncated molecule with increased biological activity and receptor binding affinity.
    Bellosta P; Talarico D; Rogers D; Basilico C
    J Cell Biol; 1993 May; 121(3):705-13. PubMed ID: 8387532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The glycine box: a determinant of specificity for fibroblast growth factor.
    Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
    Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
    Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations uncouple human fibroblast growth factor (FGF)-7 biological activity and receptor binding and support broad specificity in the secondary receptor binding site of FGFs.
    Sher I; Weizman A; Lubinsky-Mink S; Lang T; Adir N; Schomburg D; Ron D
    J Biol Chem; 1999 Dec; 274(49):35016-22. PubMed ID: 10574979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1.
    Wang F; Kan M; Yan G; Xu J; McKeehan WL
    J Biol Chem; 1995 Apr; 270(17):10231-5. PubMed ID: 7730327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes.
    Ostrovsky O; Berman B; Gallagher J; Mulloy B; Fernig DG; Delehedde M; Ron D
    J Biol Chem; 2002 Jan; 277(4):2444-53. PubMed ID: 11714710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common and specific determinants for fibroblast growth factors in the ectodomain of the receptor kinase complex.
    Wang F; Lu W; McKeehan K; Mohamedali K; Gabriel JL; Kan M; McKeehan WL
    Biochemistry; 1999 Jan; 38(1):160-71. PubMed ID: 9890894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of fibroblast growth factor (FGF) receptors by recombinant human FGF-5.
    Clements DA; Wang JK; Dionne CA; Goldfarb M
    Oncogene; 1993 May; 8(5):1311-6. PubMed ID: 8386828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblast growth factor receptor (FGFR) 3. Alternative splicing in immunoglobulin-like domain III creates a receptor highly specific for acidic FGF/FGF-1.
    Chellaiah AT; McEwen DG; Werner S; Xu J; Ornitz DM
    J Biol Chem; 1994 Apr; 269(15):11620-7. PubMed ID: 7512569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence analyses and comparative modeling of fly and worm fibroblast growth factor receptors indicate that the determinants for FGF and heparin binding are retained in evolution.
    Nagendra HG; Harrington AE; Harmer NJ; Pellegrini L; Blundell TL; Burke DF
    FEBS Lett; 2001 Jul; 501(1):51-8. PubMed ID: 11457455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains.
    Cheon HG; LaRochelle WJ; Bottaro DP; Burgess WH; Aaronson SA
    Proc Natl Acad Sci U S A; 1994 Feb; 91(3):989-93. PubMed ID: 8302878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4.
    Hecht D; Zimmerman N; Bedford M; Avivi A; Yayon A
    Growth Factors; 1995; 12(3):223-33. PubMed ID: 8619928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substitution of putative half-cystine residues in heparin-binding fibroblast growth factor receptors. Loss of binding activity in both two and three loop isoforms.
    Hou J; Kan M; Wang F; Xu JM; Nakahara M; McBride G; McKeehan K; McKeehan WL
    J Biol Chem; 1992 Sep; 267(25):17804-8. PubMed ID: 1325450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.
    Wong P; Hampton B; Szylobryt E; Gallagher AM; Jaye M; Burgess WH
    J Biol Chem; 1995 Oct; 270(43):25805-11. PubMed ID: 7592764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin differentially regulates the interaction of fibroblast growth factor-4 with FGF receptors 1 and 2.
    Aviezer D; Safran M; Yayon A
    Biochem Biophys Res Commun; 1999 Oct; 263(3):621-6. PubMed ID: 10512728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of soluble forms of the fibroblast growth factor receptor in blood.
    Hanneken A; Ying W; Ling N; Baird A
    Proc Natl Acad Sci U S A; 1994 Sep; 91(19):9170-4. PubMed ID: 8090787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
    Ibrahimi OA; Yeh BK; Eliseenkova AV; Zhang F; Olsen SK; Igarashi M; Aaronson SA; Linhardt RJ; Mohammadi M
    Mol Cell Biol; 2005 Jan; 25(2):671-84. PubMed ID: 15632068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.